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Abstract 
Neurofibrillary tangles (NFfs) and plaques are considered to be hallmarks of 
Alzheimer's disease (AD), although it is still not clear whether these aggregates 
contribute to disease progress or whether they might even play an initial protective 
role. A number of studies have shown that the small heat shock protein Hsp27 can 
afford protection against oxidative stress, growth factor withdrawal or excitotoxicity 
in neuronal cell types. A moderate preconditioning heat shock (HS) is sufficient to 
upregulate levels of Hsp27 in cells, and the degree of protection correlates with the 
level of expression of Hsp27. There are reports of increased Hsp27 in AD brains and 
accumulation of Hsps in plaques, NFfs and Lewy bodies. Whether this represents a 
potentially protective response to the stress or is part of the disease process is not 
known. My hypothesis is that increased expression of Hsp27 can promote survival 
and stabilize the axonal cytoskeleton resulting in maintenance of neurite growth and 
axonal transport in the face of stressors such as amyloid. My specific aim was to 
determine whether Hsp27 is important for neuronal survival and neurite growth in 
primary cortical neurons in the presence or absence of B-amyloid peptides. 
Cultures of primary rat cortical neurons were subjected to HS in an effort to 
upregulate endogenous Hsp27, while in other experiments Hsp27 was overexpressed 
in cortical neurons by nucleofection. Efforts to upregulate endogenous Hsp27 in 
cortical neurons were unsuccessful , despite the fact that the neurons do express heat 
shock factor-! (Hsfl) and increase activation of Hsfl in response to heat stress. In 
fact, it was seen that HS resulted in a reduction in neuronal survival, although 
previous data from our lab and the literature suggest that a thermal stress can provide 
protection against a more lethal subsequent stress. Consequently, I introduced a GFP-
Hsp27 fusion protein at the time of plating and examined the potential effects of 
exogenous Hsp27 on neurite survival and growth using morphological and 
biochemical analyses. 
My results suggest that the presence of Hsp27 in cortical neurons provides 
them with a level of protection against B-amyloid. After treatment with A~ 1 •42 , cells 
with Hsp27 appeared healthier and had greater survival than those without. 
Interestingly, A~25.35 was not shown to be toxic to these neurons, whereas it has been 
previously shown to be toxic in a variety of experimental paradigms. Further, my 
data indicate that cells expressing Hsp27 have greater total neurite growth compared 
to the empty vector alone. Knowing that phosphorylation affects Hsp27 activity, I 
also investigated the effects of Hsp27 11 on survival and growth. Hsp27 11 is a mutated 
form of Hsp27 lacking the S15 phosphorylation site. My data show that Hsp/1 has 
similar effects on neurite outgrowth and survival as Hsp27WT, providing important 
preliminary data for future studies investigating the importance of phosphorylation in 
Hsp27 activity. 
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Chapter 1 
Introduction 
Alzheimer's Disease (AD) is a neurodegenerative disease characterized by 
premature neuronal death in the presence of neurofibrillary tangles (NFfs), and 
extracellular neuritic plaques. NFfs are aggregates of hyperphosphorylated tau protein, 
whereas neuritic plaques are insoluble extracellular aggregates of A~, among other 
components. The amyloid hypothesis asserts that apoptosis is caused by the 
destabilization of the cytoskeleton in the presence of extracellular amyloid plaques 
(Mattson, 2004, Price et al., 1998, Song et al. 2002, Tanzi and Bertram, 2001). A great 
deal of investigation has been directed towards the amyloid hypothesis since the 
discovery of A~ plaques, but the direct mechanism by which amyloid acts to cause cell 
death has yet to be fully elucidated. 
Heat Shock Proteins (Hsps) are a small family of highly conserved proteins whose 
expression can be induced by stressors, such as heavy metals, elevated temperatures and 
alcohols (Hightower, 1991). Hsps have been shown to be protective, demonstrate 
chaperone activity and enhance microtubule (MT) growth and stabilization. In particular, 
the small heat shock protein (sHsp) Hsp27 has been shown to protect cells by inhibiting 
caspases and promoting Akt activity, a pro-survival signal (Mearow et al., 2002, Dodge 
et al., 2006). In other words, cells can achieve tolerance to larger more toxic stress after a 
sub-lethal stress (Hightower, 1991, Mailhos et al., 1994). For example, cells over-
expressing Hsp27 were more resistant to nerve growth factor (NGF) withdrawal, and 
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displayed less caspase-9 activation than those not over-expressing Hsp27. Similarly , 
Hsp27 has been shown to reduce apoptosis through cytochrome C and fas pathways (Patel 
et al., 2005) and thus it is not surprising that Hsp27 has been shown to attenuate caspase-3 
activation as well (Garrido et al. 1999, Mearow et al., 2002). In addition, Hsp27 appeared 
to interact with Akt and sustain its activity, demonstrating that Hsp27 plays a role in 
protecting neurons by inhibiting apoptosis and promoting survival (Mearow et al., 2002). 
Hsps have been shown to act as molecular chaperones that refold stress-denatured 
proteins and shuttle damaged proteins to the degradation pathway (Becker and Craig, 
1994, Parsell and Lindquist, 1993, Rogalla et al., 1999), two important processes 
considering that neurons are post mitotic cells that are unable to avoid deleterious protein 
aggregation by division. Furthermore, it is possible that Hsp27's protective ability may be 
independent of signaling pathways or chaperone activity. For example, Hsp27 has been 
shown to interact with the cytoskeleton (Huot et al., 1996, Lavoie et al., 1993, Miron et 
al., 1991) and some have inferred that its protective effects are due to its ability to act as 
an actin capping protein (Benndorf et al., 1994, Mounier and Arrigo, 2002). Given 
Hsp27's protective characteristics, it is possible that Hsp27 could protect CNS neurons 
from cell death caused by protein aggregation and axon destabilization, the central 
molecular pathologies of Alzheimer' s disease. 
1.1 The Amyloid Hypothesis 
Amyloid protein (A~) is strongly implicated in AD, as described by the amyloid 
cascade hypothesis (Fig. 1.1). The amyloid hypothesis, although somewhat controversial , 
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asserts that mutated A~ accumulates in protein aggregates to form plaques that lead to 
NFfs. NFfs obstruct axonal transport and causes a destabilization of the cytoskeleton 
which leads to cell death and ultimately dementia. Despite the plethora of research on AD 
and A~ (Pub Med search of "Alzheimer's" AND "Amyloid" reveals 17355 results-
http://www .ncbi.nlm.nih.gov .qe2a-proxy .mun.ca/sites/entrez) a complete description of 
the events that cause cell death is unknown. 
Formation of toxic A~ begins with proteolytic processing of the transmembrane 
protein, amyloid precursor protein (APP). APP is a ubiquitously expressed protein whose 
function remains unclear. It is thought that APP may inhibit serine proteases and play a 
role in cell adhesion and neuroprotection (Maccioni et al., 200 1) but, of more relevance 
to this thesis, it has been suggested that APP is involved in vesicle trafficking in the axon 
(Zheng et al., 1998), an interesting insight considering that a suspected pathology of AD 
is a failure of axonal stability. Interestingly, APP can be increased by stress since its 
promoter contains a heat shock element (Johnson et al., 1997). Furthermore, APP 
interacts with actin, tubulin, neurofilaments (Cottrell et al., 2005) and with kinesin I, a 
key protein in microtubule transport (Kamal et al., 2000) . This may implicate APP in 
axonal maintenance and suggest that a failure of APP processing may lead to abnormal 
axonal function and possibly degeneration. 
APP is cleaved by the multimeric gamma secretase protease complex, APH-1 
(Anterior Pharnyx Defective 1), Nicastrin and the more commonly known presenilin 1 
and 2 secretases (PS 1, Pen-2, Fig. 1.1A). Upon cleavage, the C-terminus remains as an 
amyloid intracellular domain (AICD), whose function is unknown, while theN-terminus 
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segment is released extracellularly as A~ (Fig. 1.2B). However, it may be important to 
note that transfection of certain forms of AICD have been shown to induce cell death in 
HeLa and pheochromocytoma (PC12) cells (Kinoshita et al., 2002) 
It is thought that an error in APP or its secretases leads to the production of 
erroneous A~140 or A~ 142 that fibrilize in a series of steps to form A~ aggregates that 
subsequently lead to neuronal plaques, tangles and AD (Fig. 1.1, Hardy and Selkoe, 
2002) . Genetic analysis reveals eleven pathogenic mutations in the APP, all of which are 
missense mutations located within or in close proximity to the region encoding A~ (Tanzi 
and Bertram, 2001). A~ 1 _42 deposits early in the disease and is considered to be the most 
toxic species despite the fact that it accounts for only 10% of total secreted A~ (Price et 
al., 1998). Furthermore, A~142 has a higher susceptibility to fibrilize and self aggregate 
(Harper et al., 1999, Pike et al., 1995). 
Some suggest that A~ binds the cell surface (Venkitaramani et al., 2007) 
allowing for interaction with NMDA receptors that would influence memory and 
synaptic plasticity, while others (Heredia et al., 2004) suggest that A~ can bind integrins, 
leading to the activation of cellular pathways that promote cytoskeletal remodeling. 
Furthermore, p75 has been shown to bind A~ 1 _40 (Yaar et al., 1997), A~25_35 (Kuner et al., 
1998) and A~142 (Sotthibundhu et al., 2008). Binding was shown to mediate cell death in 
neurons and as well in other experimental designs (Dechant and Barde, 2002, 
Sotthibundhu et al., 2008, Troy et al., 2002). 
Another explanation of A~ induced toxicity is that A~ aggregates form pores in 
the cellular membrane allowing for a rapid influx of ca++ and subsequent activation of 
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apoptosis (Kawahara and Kuroda, 2000, Resende et al., 2007). In these experiments, A~, _ 
42 and A~25_35 were the predominantly toxic peptides in comparison to other forms of A~ 
such as A~ 1 _40 and A~1 _28 • Similarly, Pike et al. (1993) showed that incubation of A~ 1_42 
and A~25_35 , but not A~1 _28 , resulted in neurotoxicity. On the other hand, some researchers 
suggest that A~ formation is not necessary for AD progression (Hardy and Selkoe, 2002) 
and that tangles alone can produce AD dementia. This theory is largely supported through 
the study of missense tau mutations (Hutton et al., 1998, Poorkaj et al., 1998) in other 
AD-like degenerative diseases that have NFf pathology and subsequent degradation such 
as frontotemporal dementia with parkinsonism (FfDP). Correlative studies show that 
severity of plaque formation does not correlate well with cognitive impairment (Whalen 
et al., 2005). However, in tangle diseases, like FfDP, there is no accumulation of A~ as 
seen in AD. In addition, the first APP mutant mouse generated presented with age 
dependent neuronal plaques, dystrophic neurites, hippocampus atrophy, a loss in synaptic 
density, but did not display NFfs (Masliah et al., 1996). Further, the gene encoding tau 
is not genetically linked to AD, demonstrating that tangle pathology can be mutually 
exclusive of A~ deposits (Hardy and Selkoe, 2002). Advocates of the A~ hypothesis 
suggest that tau is downstream of A~ accumulation. For example, it was shown that 
intra- and extracellular accumulation of A~ preceded NFf pathology in the 3xTg mouse, 
an AD mouse model (Oddo et al., 2004). When mice were treated with anti-A~ 
antibodies, plaques and NFfs disappeared, but when treatment was halted the deposits 
returned, followed by NFfs, showing that amyloid acts in a hierarchical manner to 
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produce NFfs (Oddo et al., 2004). Although the A~ hypothesis is controversial, it 
remains popular. 
1.2 A~ Toxicity Prior to Aggregation 
The idea that A~ plaques lie at the core of AD progression is a widely held view. 
Numerous studies have shown a correlation between aggregation state of A~ and 
neurotoxicity (Busciglio et al., 1995, Mattson, 2004, Pike et al., 1993). For example, A~ 
fibril-induced toxicity has been associated with neuronal pathology, such as axon and 
dendrite dystrophy and this toxicity was shown to be fibril dependent (Lorenzo and 
Yankner, 1994). However, the existence of soluble species that precede fibrilized A~, 
such as A~ derived diffusible ligands (ADDLs) and protofibrils (PFs), have been a recent 
area of interest (Kim et al., 2003, Klein, 2002). ADDLs are small globular structures 
approximately 5 nm in diameter whereas PFs are curvilinear shaped structures 25-200 nm 
in diameter. PFs have been shown to alter action potential and membrane depolarization 
(Hartley et al., 1999) whereas ADDLs have been shown to cause an attenuation of long 
term potentiation (Lambert et al., 1998). Not surprisingly, both PFs and ADDLs were 
shown to induce neuronal cell death. Similarly, the small soluble fragment A~25_35 
induces toxicity in the pheochromocytoma (PC12) cell line, a well characterized neuronal 
model, indicating that A~25_35 may be the biologically toxic fragment of the full length A~ 
peptide (Yankner et al., 1990). Furthermore, exposure to the A~25_35 fragment has been 
shown to result in a significant reduction in hippocampal and cortical viability (Pike et 
al., 1993). Thus, it is thought that more soluble oligomers are responsible for the 
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neurodegenerative changes that occur in AD (Costantini et al., 2005). 
Neurodegenerative changes that lead to dystrophic axons include inhibition of actin 
polymerization, cytoskeletal disruptions and disorganization, all cytoskeletal effects in a 
selective neuronal population that have been attributed to AB induced cell death. 
1.3 Amyloid and the Cytoskeleton 
A typical neuron is characterized by long thin extensions that can account for the 
largest proportion cell volume. As a result, an efficient transport system (i.e. protein, 
vesicle, and organelle transport) is necessary for viability. Any disruption or interference 
in this system can jeopardize growth, connections and cell viability. MTs and related 
proteins form a trafficking system that span from the cell body to the leading edge, where 
growth cones and synapse form , two integral constituents of a healthy neuron. Given that 
NFfs are aggregates of microtubule associated tau, it is likely that NFfs are playing a 
role in degradation by interfering with axonal transport system. For example, it has been 
shown in vitro that AB treatment can induce tau phosphorylation on epitopes the same as 
those that result in pathological hyperphosphorylated tau, followed by gradual loss of 
neuritic processes. Furthermore, phosphorylation resulted in a decrease in microtubule 
associated protein (MAP) binding that was reversible by a dephosphorylation agent, 
alkaline phosphatase (Busciglio et al., 1995). These data imply that AB treatment leads 
to tau phosphorylation, disassociation of MAPs and possibly MT instability (Michaelis et 
al., 2005). In a similar study a MT stabilizing drug, taxol, was shown to afford a 90% 
reduction in AB-induced cell death (Michaelis et al., 2005), while taxol alone (without 
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A~) did not demonstrate an increase in survival or reduction in apoptosis. This suggests 
that taxol's protective effect was due to stabilization of the axon and not mediated by 
anti-apoptotic signaling. Therefore, it may be reasonable to postulate that agents that 
stabilize MTs can provide protection, independent of cell signaling. For example, Hsp27 
has been shown to bind hyperphosphorylated tau and promote its dephosphorylation and 
degradation, thereby promoting cellular survival (Shimura et al., 2004). 
On the other hand, A~ has been shown to induce actin stress fiber formation, 
leading to disorganization and aberrant actin polymerization , resulting in clogging of the 
axon and eventual degeneration (Song et al., 2002). The actin cytoskeleton forms the 
basis for synaptic plasticity of the neuron and is dynamic in the order of seconds (Shea et 
al., 1997, Toni et al., 1999) such that, when disrupted it can lead to growth cone collapse 
and degeneration of the dendrites (Me berg and Bamburg, 2000) . In theory, these data 
provide promising research for sHsps that are known to stabilize actin and promote 
survival by acting as an actin capping protein. 
Extracellular A~ aggregates have been shown to occur prior to NFfs but recently 
it has been suggested that intracellular accumulation of A~ is a feature of early AD 
pathogenesis (Alafuzoff et al., 2008, D 'Andrea et al. , 2001 ) and that a significant 
intracellular accumulation could lead to axonal abnormalities, degeneration and neuronal 
death that precedes extracellular plaques (Takahashi et al., 2008). For example, 
transgenic mice demonstrate behavioral abnormalities prior to the accumulation of 
extracellular plaques (Chapman et al., 1999) but coincident with the intracellular 
accumulation of A~ (Wirths et al. , 2008). In the 3xTg mouse, containing mutations in 
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presenilin, tau and APP, intraneuronal accumulation of AP preceded NFT pathology and 
AP plaques (Oddo et al., 2004). Furthermore, intracellular AP has been shown to down-
regulate PI-3 kinase/ Akt survival pathways (Magrane et al., 2005) which resulted in 
neuronal death. In addition, sHsps were upregulated in response to AP but were 
insufficient to prevent cell death. Interestingly, a viral over-expression of Hsp70 has 
been shown to rescue cells from intraneuronal AP induced toxicity (Magrane et al., 
2004), showing that an exogenous over-expression of a sHsp was better able to protect 
than an endogenous one. 
1.4 Alternatives to the Amyloid Hypothesis 
Some researchers have gone even earlier into the origin of AD pathology and 
suggested an early pathogenesis in the synapse. Hardy and Selkoe (2002) suggested that 
transgenic mice undergo synaptic dysfunction before the appearance of plaque 
aggregation and that synaptic dysfunction is the earliest pathology of the disease. For 
example, AD mice bearing the V717F mutation demonstrated a 40% loss in basal 
synaptic transmission of the hippocampus between the age of one to four months, prior to 
the appearance of plaques. This is further supported by electron micrograph analysis by 
Davies et al. (1987) who reported a 25-35% reduction in synaptic density of cortical 
neurons biopsied from clinical AD patients. Furthermore, AD patients' cognitive decline 
is correlated with synaptic Joss (Scheff et al., 1990, Terry et al., 1991). Certainly, 
synaptic loss is heavily implicated as an early feature of AD (Cotman and Anderson, 
2000, Deshpande et al., 2006, Townsend et al., 2006) and neurons exposed to AP have 
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shown reduced synaptophysin immunoreactivity, suggesting a disruption or Loss in 
synaptic contacts (Busciglio et al., 2005). Interestingly, Hsp27 has been shown to be 
located in the synaptic cleft and neuronal plaques of AD brains (Stege et al., 1999) and it 
is possible that Hsp27 may be present in the cleft to provide protection, possibly through 
chaperone activity. 
Stress related genes and oxidative stress are shown to increase in the Alzheimer 
brain and it is thought that neurons may become vulnerable and die as they are exposed to 
increasing Levels of oxidative stress. For example, it has been shown that Aj3142 can 
generate hydrogen peroxide, an oxidative species that is known to cause lipid 
peroxidation that can interfere with glucose and glutamine transporters (Mattson, 2004). 
Interestingly, an upregulation of Hsp70 and Hsp27 can protect neuronal cells against 
superoxide dismutase mutant-induced cell death (Patel et al., 2005) and oxidative stress 
has been shown to have an affect on important metabolic processes such as a decrease in 
cytochrome C oxidase, pyruvate dehydrogenase and the a-ketoglutarate deyhydrogenase 
complex (Mattson, 2004), all of which have been shown to be decreased in the brains of 
AD patients (Blass, 2001). Hsp27 expression is increased in AD brains (Renkawek et al., 
1993 , 1994) but whether this augmented expression is a response to the aging process is 
unknown . However, given the known protective effects of Hsp27, it is possible that 
Hsp27 may be upregulated to reduce stress associated with AD and aging. 
Apolipoprotein E (APOE), a serum protein of four allele types (£1-4) whose 
function is to regulate cholesterol, has been implicated in AD, particularly APOE-£4 
(Price et al. 1998). The occurrences of AD patients having the APOE-£4 allele is 
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significantly greater than the control population and is highly associated with A~ plaque 
levels in the brain (Bales et al., 1997). However, the number of £4 alleles better predicts 
the age onset than the risk of getting AD. In other words, £4 predicts when, not whether, 
the disease will occur (Meyer et al., 1998) and as a result is not considered as a causative 
gene for AD. 
1.5 Alzheimer's Disease and Hsp27 
AD is a neurodegenerative disease characterized by pathology within a 
selective neuronal population that become dysfunctional and die (Mattson, 2004). 
Neurodegeneration in AD has been well characterized (Braak et al., 2006) and is 
correlated with NFfs and AB deposition (Bierer et al., 1995). Initially, cell loss includes 
magnoceJlular neurons, of the nucleus basalis of Meynert, that are located in the basal 
forebrain. These neurons are of particular importance as they are a major source of 
cholinergic projections to the neocortex (Muth et al., 2009). Following, lesions occur in 
the limbic system, particularly in the entorhinal cortex (EC) and hippocampus. In the 
final stages of AD, the neocortical lesions become more predominant and cognitive 
function is heavily impaired (Braak et al. , 2006). Clinical symptoms parallel structural 
degeneration as memory loss is followed by weakening of higher cognitive processes 
such as episodic memory and spatial orientation (Jellinger et al., 1990). Ensuing 
degeneration in the transentorhinal cortex, basal forebrain and entorhinal cortex lead to a 
progressive reduction in choline acetyltransferase and cholinergic neuronal loss (Davies 
and Maloney, 1976), consequently having a dramatic impact on cognition (Cassel et al. , 
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2008). Thus, the strong association between declining cholinergic markers and overall 
cognitive impairment (Pappas et al., 2000, Frolich, 2002) may explain the transition from 
mild cognitive impairment to full blown AD. Not surprisingly, this relationship is the 
guiding principle behind cholinomimetic therapy, the prominent drug treatment for 
dementia. 
Neurons themselves are particularly vulnerable to protein aggregation because 
they are post mitotic cells that are unable to divide to avoid the deleterious effects of 
misfolded proteins that accumulate during aging (Muchowski and Wacker, 2005). Hsps 
have been implicated in protein aggregation, axonal growth and transport and 
destabilization of neurofilaments, actin and MTs. For example, missense mutations of 
small Hsps such as Hsp27, 22 and 8 are associated with peripheral nervous system 
neuropathies, particularly the axonal form of Charcot Marie Tooth disease and distal 
hereditary motor neuropathy (Evgrafov et al., 2004, Irobi et al., 2004). Likewise, in 
vitro it has been seen that growth and complexity in dorsal root ganglion neurons (DRGs) 
is dramatically reduced following decreased expression of Hsp27 by siRNA 
oligonucleotides (Williams et al., 2006). These reports imply that an interruption of Hsp 
expression can lead to distinct phenotypes related to growth and axonal pathology. 
Furthermore, mutations in both neurofilament and Hsp27 cause similar phenotypes such 
as protein aggregation and disruption of neurofilaments resulting in pathological axonal 
transport (Ackerley et al. 2006, Evgrafov et al., 2004, Perez-Olle et al. 2004). Therefore, 
Hsps may play a role for growth, protein folding, axonal stabilization and transport, all of 
which have been shown to become pathological in Alzheimer's disease. Perhaps it is the 
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lack of expression of Hsp27 that could leave neurons vulnerable to degradation in the 
presence of stress. Knock down of Hsp70 and 90 by siRNA has been shown to lead to 
insoluble aggregates of tau that inhibits tau association with MTs (Douet al. 2003). 
Hsps are divided into 5 classes based on their molecular weight Hsp 100, 90, 70, 
60 and the sHsps, including Hsp27 , also known as Hsp25 and HspB 1 (lngolia et al., 
1982). The defining quality of Hsps is their ability to ameliorate cell insult following an 
initial sub-lethal stress. It has been shown that the degree of initial stress is correlated 
with their expression and that their ability to protect cells under a larger more significant 
cellular insult is independent of the nature of the stress. For example, a mild heat stress 
produced an equivalent ability to protect cells when under another subsequent more 
intense heat or ischemic stress (Amin et al., 1995). Furthermore, Hsp27 transgenic (tg) 
mice have shown remarkable resistance to kainate induced seizures, demonstrating less 
severe seizures and lower mortality rate in comparison to non-tg littermates (Akbar et al., 
2003). Morphological analysis revealed a reduction in atrophic changes such as cell 
shrinkage and chromatin condensation. Similarly, it was shown that Hsp27 in tg mice 
could protect motor neurons after a neonatal sciatic nerve crush where these mice later 
demonstrated significantly higher muscle mass, motor units, and muscle force contraction in 
comparison to wild type (WT) litter mates (Sharp et al., 2006). Whether Hsp27 prevented 
early neuronal death or reversed muscle damage is unclear but these data suggest that 
Hsp27 can prevent neuronal death and consequently, protect muscle function. 
It should be noted that Hsps are not constitutively expressed in all cell types and 
may require stress for their expression, while some sHsps, despite their nomenclature, are 
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not necessarily upregulated by heat stress but are known to upregulate in response to 
chemical stressors (Taylor and Benjamin , 2005). For example, aA-crystallin is almost 
exclusively expressed in the eye lens whereas a~-crystallin is expressed in eye, muscle 
cells and astrocytes (Kato et al. , 1991). Furthermore, Hsp70 is expressed at low levels in 
the brain under normal conditions but is highly inducible in response to injury such as 
hyperthermia, ischemia or seizure (Armstrong et al. 1996, Manzerra et al. , 1997, Krueger 
et al. 1999), whereas cortical neurons lack Hsp27 (Bechtold and Brown, 2003). 
1.6 Hsp27 Structure 
Hsp27's secondary structure is highly conserved with other Hsps, for example 
a~-crystallin, suggesting that Hsps could be involved in normal cell processes that are 
common between cell types and organisms. For example, Hsps are found in both 
mycobacterium and human. Hsp' s chaperone activity is known to maintain conformation 
for proteins involved in intracellular transport, cytoskeletal architecture, translation 
regulation and homeostasis (Arrigo et al., 2007), suggesting a role in regular cell 
maintenance. It has previously been shown in primary sensory neurons that Hsp27 is 
present in neurites, branch points and growth cones and is colocalized with actin, tubulin 
and neurofilament in DRG neurons , implying that Hsp27 is involved in normal growth of 
the axon. Furthermore, alterations in the phosphorylation status of Hsp27 results in 
aberrant neuritic growth, however, the exact nature of this role in not clearly understood 
(Williams et al. , 2005) . 
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Hsp27 can be post-translationally modified by phosphorylation via mitogen-
activated protein kinase-activated protein kinase-2 (MAPKAP-K2), on three residues in 
the human - S15, S78 and S82 and two residues in the rodent- S15 and S86 (Gusev et 
al., 2002). The S 15 phosphorylation site is located in the so-called WDPF domain, a 
conserved region, at theN terminus while the other phosphorylation sites are located just 
prior to the highly conserved a-crystallin domain (Fig. 1.3). At the C terminus is a 
variable, flexible and motile tail whose function remains unknown (Gusev et al., 2002, 
Sugiyama et al. 2000). Hsps form large oligomeric aggregates that can be dynamically 
modified following stress and subsequent activation of MAPK pathways (Lelj-Garolla 
and Mauk, 2005). However, it should be noted that certain isoforms of protein kinase C, 
namely PKC6 (Thr 505), can phosphorylate Hsp27 (Takai et al. , 2007). Interestingly, 
PKC6 phosphorylation has been shown to reduce A~ production by altering APP 
processing (Gabuzda et al., 1993). The MAP-kinase pathway, including p38 MAPK (p38 
mitogen activated protein kinase) and MAPKAP-K2, is activated in response to stress to 
modify Hsp activity. 
Hsp27 normally exists in a large oligomeric structure made of twenty four 
monomers forming a structure with a molecular mass of 700 kDa but upon 
phosphorylation Hsp27 can modify its structure (Kim et al., 1998) to form small dimers 
and naturally, its function is also affected. For example, phosphorylation has been shown 
to affect chaperone activity (Gusev et al., 2002) and rapid remodeling of the actin 
cytoskeleton (Guay et al. , 1997). The effect of phosphorylation on Hsp27's structure and 
function has been investigated but remains controversial. 
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1.7 Phosphorylation and Hsp27's Interactions With the Cytoskeleton 
Hsp27s chaperone activity and interactions with the cytoskeleton is heavily 
influenced by phosphorylation (Lambert et al., 1999). In unstressed cells, Hsp27 exists 
as complex oligomeric structures, but under stress Hsp27 is phosphorylated and reduced 
to smaller dimers and monomers (Lambert et al., 1999). Phosphorylation modifies its 
ability to bind actin and affect its polymerization (Benndorf et al., 1994, Guay et al., 
1997). Cell free in vitro studies suggest that Hsp27 binds and stabilizes actin filaments 
by binding to the fast growing plus end of actin filaments , acting as an actin capping 
protein (Fig. 1.4) inhibiting polymerization. However, upon phosphorylation, Hsp27 is 
modified into smaller structures and its actin capping ability becomes curtailed, thus 
promoting polymerization. It is thought that large non-phosphorylated oligomeric Hsp27 
stabilize actin via actin capping and some have suggested smaller partially 
phosphorylated Hsp27 oligomers bind MTs and prevent their degradation under stress 
(Fig. 1.5). The exact nature of Hsp27 /actin interaction is not completely known but it 
appears that post-translational modification of Hsp27 regulates dynamic modeling of the 
cytoskeleton in response to stress. 
sHsps interact with intermediate filaments such as vimentin, glial fibrillary acidic 
protein (GFAP) and neurofilaments to maintain their integrity and it appears that these 
interactions are phosphorylation dependent. Hsp27 has been shown to regulate 
interactions and assembly of both GF AP and vimentin. Some have proposed that Hsp27 
can prevent deleterious filament aggregation by regulating filament-filament interactions 
(Pemg et al. 1999). This was supported by Vicart et al. (1998) who reported a mutation 
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in sHsps can lead to intermediate filament aggregation. Others suggest that Hsp27 binds 
vimentin to maintain a soluble pool of subunits that maintain network integrity under 
stressful conditions (Lee et al., 2005). Furthermore, Hsp27 and the related a~-crystallin 
have demonstrated a similar effect in maintaining GFAP networks (Perng et al., 1999), 
suggesting a general role of Hsp involvement in neuro- and intermediate filament 
network stability. Recently, our lab has shown a co-localization of tubulin and Hsp27 in 
neurites from adult DRG neurons (Williams et al., 2005) and it has been shown 
elsewhere that Hsp27 can interact with MTs in muscle cells and some cell lines (Hargis et 
al., 2004, Hino et al., 2000). Thus , Hsp27 has been inferred not only to stabilize actin but 
neurofilaments, intermediate filaments, MTs and tubulin. 
1.8 Summary 
Hsp27 has been implicated in AD. Hsp27 has been found in amyloid plaques, the 
synapse and colocalized with cytoskeletal elements (i.e. neurofilament, intermediate 
filaments, MAPs and transport proteins such as kinesin) that are responsible for the 
integrity of the axon; the axon being particularly important to neuronal survival. This 
suggests that Hsp27 may be interacting with the cytoskeleton and playing a role in 
normal cell functions, where a failure of these functions could lead to AD pathology. 
Hsp27 exhibits anti-apoptotic and pro-survival activity, suggesting a role in regulating 
cell death. Further, Hsp27 has been implicated in normal axonal growth, transport and 
chaperone activity indicating that an error in these processes could jeopardize neuronal 
viability. Chaperone activity is particularly important because neurons are post mitotic 
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cells that can not avoid protein aggregation via cell division. The presence of Hsp27 in 
A~ plaques may indicate a failed attempt to rescue neurons , but whether this is part of the 
disease process is unknown. Recently, Hsp 70 and 90 have been shown to inhibit the 
early stages of A~1 _42 aggregation in vitro (Evans et al., 2006) and this action may be 
chaperone based. Given the protective effects of Hsp27 and its ability to upregulate 
under stress, it is reasonable to think that an over-expression of Hsp27 may be able to 
provide protection against A~ induced toxicity. 
1.9 Hypothesis 
My hypothesis is that increased expression of Hsp27 can promote survival and 
stabilize the axonal cytoskeleton resulting in maintenance of neurite growth and axonal 
transport in the face of stressors such as amyloid. 
1.10 Objectives 
• Aim#l. To determine Hsp27 expression and upregulation in cortical neurons. 
• Aim#2. To investigate whether Hsp27 is important for neuronal survival in the 
presence or absence of B-amyloid peptides. 
• Aim#3. To explore the effect of Hsp27 on neurite length in cortical neurons and 
the effects of phosphorylation in neurite outgrowth. 
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Figure 1.1. Proposed Amyloid hypothesis (Adapted from Hardy and Selkoe, 2002). 
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Figure 1.2. Schematic representation of APP processing by the gamma secretase 
complex. (A) The gamma secretase complex (B) cleaves APP into an intracellular 
(AICD) and extracellular fragment. The purpose AICD is unknown whereas, according 
to the Amyloid hypothesis, Ap 1_40 and AP 142 aggregate and become toxic (Copyrights for 
figure obtained from Nature, Mattson, 2004). 
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aB - crystallin 
Figure 1.3. Schematic representation of Hsp27 and the related a~-crystallin. (Adapted 
from Gusev et al., 2002). 
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Figure 1.4. Hsp27 binds the growing end of actin , reducing its polymerization. Under 
stress Hsp27 is phosphorylated, via the MAPKAP-K2 pathway, and demonstrates 
reduced ability to bind actin, thus increasing polymerization. 
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Figure 1.5. Schematic representation of Hsp27's phosphorylation dependent interaction 
with actin. (A) In unstressed cells, Hsp27 exists as a large oligomeric structure. However, 
after stress and subsequent phosphorylation, Hsp27 is reduced to monomers dimers and 
oligomers (B). Phosphorylated products bind MTs whereas non-phosphorylated 
monomers bind to the fast growing end (C) (Adapted from Mounier and Arrigo, 2002). 
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2.1 Neuronal Cultures 
Chapter 2 
Materials and Methods 
Brains were removed from post natal day one (P1) Sprague Dawley rats supplied 
by Memorial University of Newfoundland Animal Care Facility. Animals were sacrificed 
by rapid decapitation prior to tissue removal and cortex and/or hippocampi were isolated 
in cold Hanks Balanced Salt Solution (HBSS, 1 mM, Invitrogen, Burlington, ON, 
Canada). Subsequently the tissue was immersed in 37 oc (HBSS, Invitrogen, Burlington, 
ON, Canada) containing 0.125% Trypsin (Invitrogen, Burlington, ON, Canada) for 15 
min. Trypsin solution was removed and tissue was rinsed with 37 oc HBSS. Soybean 
Trypsin inhibitor (2 mg/rnl, pH to 7.2 using 1N NaOH, Invitrogen, Burlington, ON, 
Canada) was added and incubated for 5 min at 37 octo inactivate remaining trypsin. 
Cells were then rinsed and triturated in dissection media [Eagles minimum essential 
media (EMEM, Invitrogen, Burlington, ON, Canada), supplemented with 10% fetal calf 
serum (FCS), 10 mM Sodium Bicarbonate and 20 mM Potassium Chloride] using a pre-
wetted 5 ml pasteur pipette. Trituration occurred in 3 steps of 5 triturations each, 
removing suspended cells after each step. Cells were then washed from debris with 
dissection media until clean, isolated by centrifugation for 5 min at 225 ref and counted 
using a haemocytometer. Three wash steps with warm dissection media were performed 
in order to remove non-cell tissue and aggregates of dead cells. Cells were counted and 
plated on poly-D-lysine (1 !lg/ml, coated 12-well plates, Falcon, VWR, Mississauga, ON, 
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Canada) for Western blot analysis or 16-well glass slides (LabTek, VWR, Mississauga, 
ON, Canada) for neurite growth and survival analysis. Cells were plated in serum-free 
Neurobasal medium (NB, Invitrogen, Burlington, ON, Canada) supplemented with 100 
U/ml penicillin/streptomycin, 2% B-27 supplement and 1 mM HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, Invitrogen, Burlington, ON, Canada). 
Typically, 1.5 x 106 cells/ml were plated for protein collection, whereas 2.0 x lOS cells/ml 
were plated for immunocytochemical experiments. Two days after plating, cell culture 
media was supplemented to 10 mM cytosine arabinoside and at this time, experimental 
conditions were treated with B-amyloid peptides (25-35, 1-42, rPeptide, Bogart, GA, 
USA) or their reverse peptide control (35-25, rPeptide, Bogart, GA, USA) . All 
experimental manipulations were carried out after 2 days in vitro (div) in order to allow 
neurons to recover from the dissociation process. Cell cultures were heat shocked for 15 
min at 45°C and subsequently incubated for varying periods of recovery time (3, 6, 12, 
24 and 48 hr). 
2.2 Transfection 
Cells were transfected at the time of plating with Amaxa nucleofector (Amaxa 
biosystems, Walkersville, MD, USA) according to manufacturer's protocol. Three 
constructs were employed: i) pMaxEGFP (enhanced green fluorescent protein) , control 
empty vector (EV), ii) EGFP-Hsp27 fusion protein (WT), which have previously been 
shown to be functional in PC12 cells (Mearow et al. 2002) and iii) EGFP-Hsp27 !1. After 
trituration, cells were counted using a haemocytometer, and 5.5 x 106 cells were 
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pelleted by centrifugation for 5 min at 225 ref and resuspended in 100 ~1 of Amaxa 
transfection solution containing 82 ~1 of Amaxa nucleofector solution and 18 ~1 of 
supplement. Cell suspensions were mixed with 5 ~g of DNA, added to Amaxa cuvette 
and transfected using the G-13 program for hippocampal or cortical neurons. 
Immediately after transfection, cells were resuspended in EMEM plating media and 
allowed to recover in an incubator for 30 min at 5% C02 and 37 °C. Finally, cells were 
plated in serum-free NB supplemented with 100 U/rnl penicillin/streptomycin, 2% B-27 
supplement and 1 mM HEPES (Invitrogen, Burlington, ON, Canada). 
2.3 Immunocytochemistry 
Neurons were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) 
for 20 min then permeabilized with 0.1% Triton-X and blocked with 10% goat serum. 
Primary antibodies employed included polyclonal Hsp27 (1:200, Stressgen,Victoria, BC, 
Canada),and beta III tubulin (1:100, Sigma Chemicals, St. Louis, MO, USA). Cells were 
incubated with primary Ab for 16-20 hr at4°C, rinsed with PBS and incubated with Cy2 
and Cy3 conjugated secondary antibodies (1: 100, Jackson Laboratories, Bar Harbor, ME, 
USA) for 1 to 2 hr. Cells were finally rinsed in TBS/TBST (Tris-buffered saline/Tris-
buffered saline with 0.5% Tween) and coverslipped with 50% glycerol. Images were 
acquired in each of two channels (Cy2, and Cy3) using confocal scanning microscopy 
with sequential Z-stage scanning (Olympus Flouview 300 microscope). 
39 
2.4 Biochemical Analysis 
Neurons were collected by aspirating the medium, adding 200 ~-tl ice cold TBS 2 
mM sodium orthovanadate solution and scraping neurons off the plate surface using a 
rubber scraper. Cells were pelleted for 5 min at 1310 ref, suspended in ice cold protein 
lysis buffer (1% NP40, 10% glycerol in TBS plus protease inhibitor tablets, 1 rnM 
sodium vanadate and sodium fluoride, all obtained from Sigma Chemicals, St. Louis, 
MO, USA) and stored in -20°C until Western blot analysis. All protease inhibitor tablets 
were obtained from Roche Diagnostics (Laval, Quebec, Canada). Lysates were thawed 
on ice and subsequently centrifuged for 10 min at 8160 ref and the supernatants were 
used to determine protein concentrations using the BSA protein assay kit (Pierce 
Chemicals, Rockford, IL, USA). Sample buffer [10% glycerol, 2% sodium dodecyl 
sulfate (SDS), 0.1 M dithithreitol (DDT), 0.005% bromophenol blue] was added to 30 !J.g 
of protein lysate, boiled for 5 min and then separated by SDS-PAGE for,., 1.5 hr at 11 OV, 
40 rnA on a 10% acrylarnide gel. Electrophoresis was run in electrophoresis buffer [25 
mM Tris base, 250 mM glycine (pH 8.3), 0.1% SDS)]. Subsequently, separated proteins 
were transferred onto nitrocellulose membrane in a transfer tank at 100 V, 200 rnA, 4 oc 
for 55 min. Each blot was then stained with Ponceau Red to ensure equal protein; 
Ponceau Red was washed off with TBS and blots were blocked with 3% rnilk/TBS prior 
to antibody incubation to avoid non-specific binding. Nitrocellulose blots were incubated 
at 4 oc overnight with the following antibodies: Hsp27 (1: 1000, Hsp27-Ab 801, 
Stressgen, Victoria, BC, Canada), phosphospecific Akt (1:500), phospho-p38 MAPK 
(1:500), Akt (1:1000), p38 MAPK (1:1000) (NEB/Cell Signaling, Beverley, MA), and 
40 
actin (1: 1000, Sigma Chemical, St. Louis, MO, USA). Blots were then washed in TBST 
(3 x 15 min) and signals were detected using horseradish peroxidase (HRP) labeled 
secondary antibodies in 3% powdered milk (1:5000, Chemicon, Temecula, CA, USA) 
and ECL reagent (NEN, Boston, MA, USA). Films (Cronex MRF clear base, Agfa 
Corp., Greenville, SC, USA) were developed, subjected to densitometry using ImageJ 
(National Institute of Health (NIH), Bethesda, Maryland, USA) and prepared using 
Adobe Photoshop graphics software (San Jose, CA, USA). 
2.5 Growth Analysis 
Confocal laser scanning microscopy was used to obtain images and neurons were 
then traced using a semi-automated tracing plug-in NeuronJ within Image J software 
(NIH, Research Services Branch, Bethesda, Maryland, USA). Total neurite length is the 
sum of all axons and dendritic processes from a single neuron measured in ~J.m and each 
data point represents at least 45 neurons from multiple experimental replicates. 
2.6 Peptide Preparation 
Ultra pure AB1_42 peptide was prepared by manufacturer's (rPeptide) instructions. 
White lyophilized powder was re-suspended in 1% NH40H at a concentration of 1 mg/ml 
and sonicated until dissolved. Amyloid peptide solution was then aliquoted, stored at -80 
oc and thawed on ice before use. Peptide was not incubated for fibril formation prior to 
treatment. Peptide (or reverse 35-25 scrambled peptide) were added to cultures on 2 div 
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and incubated for varying periods of time {4, 6, 12, 24, and 48 hr). Final peptide 
concentrations of A13 142 and Al325.35 were 5 ~-tM and 25 ~-tM, respectively. 
2. 7 Statistical Analysis 
Statistical analysis was performed in GraphPad Prism 4.0 (GraphPad Software 
Inc., La Jolla, CA, USA) with significance determined by one-way ANOV A testing. 
Post-hoc t-tests were carried out after ANOVA testing to directly compare two groups. 
Significance was determined when p < 0.05 and figures display mean values ± SEM. 
2.8 Survival Assays 
MTS . An initial measurement of survival was assessed using the MTS (3-( 4,5-
dimethylthiazol-2-yl-5-(3-carboxymethoxyphenyl)-2-( 4-sulfonphenyl)-2H-tetrazolium 
compound) assay. The MTS assay is an indirect assessment of survival where MTS IS 
converted into formazan by mitochondria, producing a color change detectable at 
490nm. Decreased absorbance is an indication of decrease in mitochondrial metabolism, 
which has been correlated with decreased cell survival (Mosman eta/., 1983). 
Trypan Blue. The Trypan blue exclusion dye assay was used to investigate the 
effects of AJ3 types on cell survival at the individual cell level. Trypan blue dye is 
excluded from cells with intact membranes but cells that take up the dye are considered 
to have damaged membranes causing increased cellular permeability. 5 ~-tl of 0.4 % 
trypan was added to each chamber of a 16 well slide and incubated for 30 min with 5% 
C02. Wells were then twice rinsed with PBS and photographed using a light microscope 
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and camera. Survival was assessed over several fields of view and neurons positive for 
trypan dye were counted relative to total number of cells. 
2.9 Constructs 
Three constructs were employed for transfection of cortical neurons: EGFP, 
EGFP- Hsp27WT, EGFP- Hsp27Delta ( ~) . Hsp27 eDNA for Hamster was generously 
donated by Dr. Jacques Landry (Universite de Laval, Quebec City) , sub-cloned into 
pEGFP-C2 vector (Clontech Laboratories, Palo Alto, CA), the empty vector (EV), and 
was transfected into neurons at the time of plating using Amaxa. The deletion construct 
was mutated, sequenced and cloned into the same pEGFP-C2 construct. 
Esp 31 (2667) 
Esp 31 (7) 
Eco 311 (18) 
Nsil (27) 
pmaxGFPr~o~ 
(3486 bp) 
BspTI (1891) 
Eco311 (1896) 
Esp31 (1909) 
Bglll (1676) 
Xhol (1680) 
Sacl (1687) 
EGFP 
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Kpnl (980) 
Nhel (988) 
Eco47111 (993) 
Agel (997) 
----------·--
EGFP - Hsp27WT 
EGFP - Hsp27 ~ 
Figure 2.1. Schematic representations of EGFP, Hsp27WT and Hsp27~ construct. 
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Chapter 3 
Results 1 
A number of studies have shown that the small heat shock protein Hsp27 can 
afford protection against oxidative stress, growth factor withdrawal or excitotoxicity. A 
moderate preconditioning heat stress (HS) is sufficient to upregulate levels of Hsp27 in 
cells, and the degree of protection correlates with the level of expression of Hsp27 
(Mearow et al. 2002). For example, cell types previously studied in our lab (DRG 
neurons and PC12 cells) have been shown to upregulate Hsp27 expression in response to 
heat shock (Mearow et al., 2002, 15 min at 45°C). However, previous research has 
shown that rat cortical neurons do not normally operate to express detectable levels of 
endogenous Hsp27, although others have shown Hsp27 in non-neuronal cells (Bechtold 
and Brown, 2003). Consequently, my first aim was to investigate Hsp27 expression in 
untreated and heat shocked cortical cell cultures. 
3.1 Endogenous Hsp27 expression is not detected in cortical neurons 
In order to examine the expression of Hsp27 in cortical neurons in culture, cells 
were plated on 12 well plates or 16 well slides. Some cells were subjected to heat shock 
to evaluate whether this could upregulate Hsp27. Protein lysates were extracted for 
Western blot analyses. Previous studies in our lab demonstrate that Hsp27 is robustly 
1 These results have been included in a recent publication. King M, Nafar F , Clarke J and 
Mearow M (In Press) The small heat shock protein, Hsp27, protects cortical neurons 
against the toxic effects of ~-amyloid . Journal of Neuroscience Research. 
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expressed in DRG neurons (Williams et al., 2005) and thus a DRG sample was used as a 
positive control. Fig. 3.1 shows that Hsp27 is strongly present in positive control sample 
but not in control or heat shocked cortical cells. This result confirms previous research 
that Hsp27 is not present in cortical neurons. We also assessed the effect of HS on the 
viability of the cultures (Fig. 3.2). It was seen that HS resulted in degenerative processes 
and cell death after 24 and 48 hr. 
Consequently, it was necessary to find another means to express Hsp27 in cortical 
neurons to test the hypothesis of my project. Thus, I attempted to transfect neurons with 
EGFP-Hsp27WT eDNA using Amaxa transfection. This procedure results in 30-40% 
transfection as assessed visually in Fig. 3.3A, B, C and Western blot in Fig. 3D 
demonstrating that Hsp27 is expressed in transfected neurons but not in EV conditions. 
Note that because several different conditions were run on this particular gel , the 
pertinent lanes have been selected for presentation. The complete blot is attached in the 
appendices (Fig. 5.1). Successful expression of EGFP-Hsp27Wt eDNA in preliminary 
experiments allowed me to investigate Hsp27's effects on survival in cortical neurons. 
3.2 A~1 42 but not the small A~25_35 fragment has deleterious effects on neurons 
Given the variety of A~ species used in AD research, it was pertinent to examine 
the effects of multiple A~ types on cortical neurons in vivo. A~ 1 _42 and A~25_35 have shown 
to be toxic in several experimental paradigms (Kawahara and Kuroda, 2000, Kim et al., 
2003, Pike et al., 1995, Price et al., 1998, Resende et al., 2007). Therefore, prior to my 
investigation of aim #2, I conducted preliminary experiments that investigated the effects 
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Figure 3 .1. Western blot and accompanying densitometry shows undetectable levels of 
Hsp27 in untransfected cells. Cortical neurons were plated on poly-0-lysine coated 
dishes and allowed to mature for two days in culture. Cultures were heat shocked for 15 
min at 45°C and allowed to recover for 24 and 48 hr. Hsp27 is not detectable at 24 or 48 
hrs post HS . All data in figure is displayed as mean± SEM. *** p < 0.0001 n=2 
(ANOVA). 
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Figure 3.2. Heat shock reduces survival of cortical neurons as assessed by the trypan blue 
assay. In other cell systems, heat stress can be used to upregulate Hsps that can provide 
some level of protection against subsequent stressors. However, my study shows that heat 
shock results in neuronal death. Cultures were subjected to a mild heat stress of 45 °C for 
15 min and allowed to recover for either 24 or 48 hr before analysis. Survival was 
assessed using trypan blue staining and neurons positive for trypan dye were counted 
relative to total number of cells . Control conditions did not receive a heat shock (A) and 
phase micrographs provide an example of normal and heat shock conditions at 24 and 48 
hr (B). Images a and c depict control neurons for 24 and 48 hr respectively and images b 
and d show neurons treated with HS. Note that cells in heat shock conditions show clear 
degeneration, indicated by arrows. All data in figure is displayed as mean± SEM. 
*p < 0.001, ***p<0.0001 (ANOVA) n=3. 
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Figure 3.3. Neurons can be successfully transfected with vectors. Neurons were plated 
on poly-D-lysine coated 12 wells or 16 well slides and transfected at the time of plating 
with either EV or WT eDNA using Amaxa nucleofector. Neurons were either collected 
for Western blot or immunostained at 48 hr with an antibody directed against Hsp27. 
Confocal and phase contrast images show that approximately 30-40% of neurons were 
successfully transfected (A). Hsp27-GFP is detectable by immunohistochemistry but not 
detectable in untransfected cells (B). Neurons in panels' a-c show transfection with the 
EV (b, green) but display no detectable levels of endogenous Hsp27 (a). Merged image 
(c) shows that only EV is present. Neurons in panels d-f show co-localization of the 
Hsp27WT eDNA (e, green) with immunostaining for Hsp27 (d, red). Merged image 
showing co-localization can be seen in (f). (C) Shows a typical neuron positive for the 
neuronal specific marker beta III tubulin (a, red), Hsp27 (b, green) and a merged image 
showing co-localization of tubulin and Hsp27 (c). Western blot and accompanying 
densitometry (D) demonstrates successful Hsp27-GFP expression. Blot was probed with 
antibody against Hsp, which recognizes the fusion protein at 54 kDa, only in the WT 
lanes. The apparent band in the EV lanes is an artifact of cutting the blot. All data in 
figure is displayed as mean± SEM. ***p<0.0001 n=2 (ANOVA) 
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of A~ 1 _42 and A~25_35 on untransfected cells to provide a baseline for future experiments 
investigating their effect on neurons transfected with Hsp27WT eDNA. Control 
conditions for A~ 1 42 did not receive a peptide, whereas A~25_35 controls received the 
reverse control peptide A~35_25 . 
3.2.1 A~ 1 _42 but not A~25_35 affects untransfected naive cortical neurons 
To investigate the effect of amyloid on cortical neurons , I exposed untransfected 
cells to A~ fragments and observed the effect at 24 and 48 hr time points. Earlier time 
points (4, 6, and 12 hr) were observed but neuronal survival was not affected. It has been 
suggested that A~ fibril formation is necessary for neurotoxicity, but recently it has been 
shown that species that precede fibrilized A~ are responsible (Kim et al., 2003, Klein, 
2002). Further, soluble A~ was shown to have CNS neurotoxic specificity. Therefore, in 
my experiments the A~ peptide was not preincubated for fibril formation prior to 
addition. Photomicrographs in Fig. 3.4 show the differential effect of A~ types on 
morphological characteristics. Those cells exposed to A~ 142 show clear degeneration, 
indicated by arrows, whereas cells exposed to Aj335_25 and Aj325_35 remain apparently 
healthy. To quantify this, a trypan blue exclusion assay was used. Trypan blue dye is 
excluded from cells with intact membranes but cells that take up the dye are considered 
to have damaged membranes causing increased cellular permeability. Neurons were 
photographed using a light microscope and analyzed using ImageJ software. Cells 
positive for trypan dye were counted relative to total number of cells and survival was 
measured as percent of control. Results in Fig. 3.5A show that Aj3142 exposed neurons 
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Figure 3 .4. Phase micrographs provide an example of cortical cultures under different 
experimental conditions. Panels' a-d show cultures in absence or presence of A~ 142 . a-
control at 24 hr, b- A~1 _42 at 24 hr, c- control at 48 hr, d- A~142 at 48 hr. Arrows show 
clear degeneration in a-d, whereas neurons in e-h treated with A~25_35 do not. e - control at 
24 hr, f - A~25_35 at 24 hr, g - control at 48 hr, h - A~25_35 at 48 hr. Degeneration indicated 
by arrows. 
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Figure 3 .5. Af3142 but not Af325_35 kills untransfected neurons. Cell survival was 
determined using 0 .4% trypan blue solution and cells positive for trypan blue were 
counted in relation to total number of cells per well of a 16 well chamber slide. Values 
are presented as% of untreated control (control not shown). (A) Shows significant cell 
death at 48 hr from Af3 142 • However, (B) demonstrates that Af325.35 does not result in a 
decrease in survival at 24 and 48 hr time points. Each data point represents several 
hundred neurons from at least 6 fields of view from multiple experimental replicates 
(n=3) . All data in figure is displayed as mean± SEM. *p < 0 .05. (t-test) 
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display a significant reduction in survival at 48 hr while A~25_35 exposed neurons do not 
(Fig. 3.5B). Previous research (Pike et al., 1993) reported A~25_35 to be toxic to cortical 
neurons at a similar concentration and time point but our data indicates otherwise. On the 
other hand, A~142 has been shown to be toxic to neurons (Evans et al., 2006, Mattson, 
2004, Pike et al., 1995, Price et al., 1998) and our results confirm this in vitro. Based on 
these results, I then implemented a similar experimental paradigm on transfected neurons 
to address specific aim #2, the effect of Hsp27 on survival. 
3.3 EV and Hsp27WT transfected neurons treated with amyloid show differential 
absorbance in the MTS survival assay 
In order to investigate the effect of Hsp27WT eDNA on survival against A~142 
and A~25.35 I used the MTS colorimetric assay. Cells were transfected, plated in 96 well 
chambers and exposed to A~142 , A~25_35 or its control A~35_25 peptide for 24 hr. The MTS 
assay is an indirect assessment of survival where MTS is converted into formazan by 
mitochondria, producing a color change detectable at 490 nm; decreased absorbance is an 
indication of decreases in mitochondrial metabolism which has been correlated with 
decreased cell survival (Mosmann, 1983). Absorbance values for A~ treated wells were 
expressed relative to their controls and are displayed in Fig. 3.6 Results indicate that 
A~ 142 treated wells demonstrate a significant reduction in absorbance, indicating 
decreased metabolism confirming our preliminary data in untransfected neurons. More 
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Figure 3.6. A~ 1 _42 but not A~25_35 causes significant reduction in neuronal survival. 
Neurons were transfected with either EV or Hsp27WT eDNA, plated on poly-D-lysine 
coated 96 well plates and allowed to recover for 2 days in culture. Cells were exposed to 
A~35_25 , A~25_35 or A~ 1_42 for 24 hr and then subjected to a MTS colormetric assay 
measured at 490 nm. Neurons treated with A~25_35 were also subjected to a trypan blue 
assay. Absorbance reflects whole well metabolic activity which in turn reflects survival. 
All conditions are expressed as % of untreated controls (control not shown). A reduction 
in absorbance is seen for EV and WT transfected cells treated with A~1 _42 but not A~25_35 
or its control peptide A~35_25 • (A). WT transfected neurons demonstrate higher absorbance 
than EV in A~ 1 _42 treated wells (B). (C) Shows that A~25_35 does not result in reduced 
neuronal survival as determined by trypan blue assay. Cells positive for trypan blue were 
counted in relation to total number of cells per well of a 16 well chamber slide. Each 
condition is composed of absorbance readings from seven wells and trypan data is 
composed of at least 30 neurons, over at least 6 fields of view per condition. All data was 
composed of multiple experimental replicates (n=3). All data in figure is displayed as 
mean± SEM. *** p < 0 .0001 (ANOVA) and *** p < 0.0001 (t-test) 
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interestingly, it was seen that Hsp27WT eDNA neurons showed greater absorbance than 
EV transfected neurons (Fig. 3.6B). This may indicate that Hsp27WT eDNA increases 
neuronal survival. Given that MTS is an indirect measurement of cell survival, I also 
used the trypan blue exclusion dye assay to more accurately investigate the effects of A~ 
types on cell survival at the individual cell level. It can be seen in Fig. 3.6C that A~25_35 
did not have an effect on survival in either the EV or WT condition, reiterating the result 
found in the previous section that A~25_35 treatments do not appear to reduce survival, at 
the concentration used in the time points investigated. 
3.3.1 Neurons transfected with Hsp27WT eDNA show greater survival against A~1 .42 
than EV transfected neurons. 
Given that A~ 1 _42 but not A~25_35 was shown to be toxic, I continued to investigate 
the effects of A~ 1 _42 but not A~25_35 • In addition, I sought to determine the effects of A~ 142 
treatment on transfected neurons. Cells were plated on 16 well slides and treated with 
A~ 1 _42 for 24 and 48 hr. Trypan blue dye was used to determine the effect of Hsp27WT 
eDNA on survival. Cells positive for Trypan dye were counted relative to total number of 
transfected cells and survival was measured as percent of control (Fig. 3.7). EV 
transfected cells show a 17% decline in survival at 48 hr following ABI-42 treatment, 
while EGFP-Hsp27WT transfected cells do not (2% decline). This result indicates that 
transfection of Hsp27WT eDNA has a protective effect after A~ 1 _42 treatment. To my 
knowledge this is the first time that transfection of Hsp27WT has been shown to protect 
cortical neurons against A~1 _42 treatment. 
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Figure 3.7. Hsp27 eDNA can enhance survival of amyloid-treated neurons. Cells were 
transfected at the time of plating on poly-D-lysine coated slides and allowed to recover 
for two days in culture before being exposed to Aj31_42 • Cell survival was determined 
using 0.4% trypan blue solution. Cells positive for trypan blue were counted in relation to 
total number of cells per well of a 16 well chamber slide. Values are presented as% of 
untreated controls (control not shown). EV cells shows a significant decrease in survival 
at 48 hr time point, while WT cells remain at control levels . Data is composed of at least 
30 neurons from multiple experimental replicates (n=3). All data in figure is displayed as 
mean± SEM. *p < 0.05, ***p<O.OOOl. (ANOVA) 
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Knowing that Hsp27 has been shown to regulate cell death/survival pathways 
(Havasi et al. 2008, Mearow et al., 2002, Patel et al., 2005), I investigated the effect of 
Ap,_42 treatment on stress/survival related mechanisms such as activation of p38, Akt, 
PKCo, and caspase-3 through Western blot analysis, particularly their activated forms. 
Western blot and accompanying densitometry in Fig. 3.8 shows a reduction of activated 
p38 (phospho-p38) in Hsp27WT transfected cells in comparison to those transfected with 
EV. However, these results were not significant. Unfortunately, my investigation of 
other signaling proteins is not presented here because it did not reveal a clear response. 
Hsp induction has been shown to be specific to stressor type (Taylor and 
Benjamin, 2005). Consequently, it was possible that Ap1_42 could upregulate endogenous 
Hsp27. To investigate this possibility, I treated neurons with AP 142 for 24 and 48 hr and 
analyzed protein lysates by Western blot. Data presented in Fig. 3.9 shows that Ap 1_42 
treatment does not result in increased endogenous Hsp27 expression confirming the 
previous result that Hsp27 is not expressed in cortical neurons. 
3.4 Hsp27WT and Hsp27 /!:,.eDNA increases neurite length at 24 and 48 hr time points. 
Previous studies indicate that Hsp27 plays a role in axonal outgrowth and 
stabilization. Furthermore, Hsp27 has been shown to interact with actin, MAPs (e.g. tau) 
and intermediate filaments. Knowing this, I decided to examine whether Hsp27 might 
have a similar effect in cortical neurons. It is possible that Hsp27's protective effects 
could be a result of axonal growth and stability. To that end, I transfected neurons and 
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Figure 3.8. p38 is less active in WT transfected cells, as indicated by phosphorylated p38 . 
p38 is part of the stress associated MAP-kinase pathway that leads to the phosphorylation 
of Hsp27 (Gusev et al., 2002). In my study I sought to investigate p38 activity in 
response to A~ 1 _42 treatment. Neurons were transfected at the time of plating with either 
EV or WT eDNA using Amaxa nucleofector and allowed to recover for 2 days in culture. 
Cells were exposed to A~ 1_42 for 24 hr and collected for Western blot analysis. P-p38 was 
measured relative to its inactive p38 form and Western blot was subjected to 
densitometry. Western blot and accompanying densitometry shows that those cultures 
transfected with Hsp27WT demonstrated less active p38 than those cultures transfected 
with EV. It should be noted that this result was not significant. Figure represents data 
from two separate blots and is displayed as mean± SEM (ANOVA) n=2. 
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Figure 3.9. Western blot shows undetectable levels of endogenous Hsp27 in 
untransfected and transfected cells treated with A~ 1 _42 • Cortical neurons were plated on 
poly-D-lysine coated dishes, allowed to mature for two days in culture and then treated 
with A~ 1 _42 for 24 and 48 hr. Western blot shows that Hsp27 is not detectable at 24 or 48 
hr after A~1 _42 treatment. 
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measured the influence of Hsp27 neurite outgrowth using confocal microscopy and 
ImageJ neuron tracer. 
Cells were transfected at the time of plating on 16 well glass slides and fixed at 24 
and 48 hr time points. In order to measure cell neurites, cells were immunostained with 
total neuronal tubulin antibodies and photographed using confocal microscopy. Neurons 
were photographed using confocal imaging and traced using NeuronJ and total neurite 
length is displayed in Fig. 3.10. Total neurite length was obtained by tracing all 
processes from at least 45 separate neurons from each experimental condition and data 
expressed as the mean from three replicate experiments. Control neurite lengths were 
measured using untransfected neighboring cells; there was no difference in neurite length 
between EGFP and untransfected cells (data not shown). Results in Fig. 3.10A indicate 
that Hsp27WT eDNA resulted in an increase in total neurite length over 48 and 72 hr 
time points. This indicates that Hsp27WT eDNA increases growth in cortical neurons. 
Knowing that phosphorylation affects Hsp27 function in DRG neurons (Williams 
et al., 2005), I also sought to determine if mutated versions of Hsp27 (i.e. the 1:1 mutation 
missing the WDPF domain) had a differential effect on neurite outgrowth. Results in Fig. 
3.1 OB and C show that neurons expressing Hsp27 1:1 show increased neurite length 
compared to controls (B), but have similar neurite length as full length Hsp27WT (C) . 
This result implies that the S 15 phosphorylation site and surrounding amino acids are not 
important for increasing neurite length. Representative photos (Fig. 3.10D) illustrate 
typical neurons in each condition at 48 and 72 hr time points. 
72 
Figure 3.10. Wild type Hsp27 results in increased total neurite growth at 48 and 72 hr. 
Cortical neurons were transfected with empty vector, Hsp27~ or Hsp27WT eDNA , 
plated on poly-D-lysine coated slides and immunostained with an antibody directed 
against neuronal tubulin. Delta-Hsp27 is mutated Hsp27 excluding the WDPF domain 
and consequently the S15 phosphorylation site. Confocal laser scanning microscopy was 
used to photograph neurons and NeuronJ, an lmageJ plug-in, was used to trace neurite 
length. (A) shows that transfection of EGFP-Hsp27WT increases neurite length. 
Similarly, (B) shows that EGFP-Hsp27 !i transfected neurons significantly increase 
neurite length but not in comparison to WT conditions (C). Confocal images in (D) 
provide representative examples of neurons transfected with EV and WT constructs. 
Images a-c represent typical neurons traced at 48 hr from EV, WT and !i conditions, 
respectively, while d-f represent neurons traced at 72 hr. Total neurite length is the sum 
of all axons and dendritic processes from a single neuron and each data point represents 
at least 45 neurons from multiple experimental replicates (n=3). All data in figure is 
displayed as mean± SEM. ***p<O.OOOl (ANOVA). 
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3 .4.1 Hsp27 L1 mutation shows similar survival effects as Hsp27WT. 
Based on the literature and previous data from our lab (Gusev et al., 2002, 
Williams et al., 2005), it is known that post translational modification of Hsp27 (i.e. 
phosphorylation) affects its function. Therefore, in addition to Hsp27 L1 effect on neurite 
length, I sought to investigate the effect of Hsp27 L1 on survival. To that end, I transfected 
and plated neurons on 96 well plates and performed the MTS assay after 24 hr of Aj325_35 
and Aj3 1•42 treatment. Results are presented as percent of control in Fig. 3.11 . As before, 
results show that Aj3142 but not Aj325_35 causes a reduction in absorbance, suggesting that 
Aj3 142 , and not Aj325_35 , is the toxic species (Fig. 3.11A). Fig. 11B shows that cells 
transfected with Hsp27 L1 have greater survival than EV neurons but equal to Hsp27WT 
(Fig. 3.11 C). Hsp27WT and Hsp27 L1 constructs do not differentially affect survival 
according to the MTS assay. This data suggests that Hsp27 L1 is as effective at protecting 
neurons as Hsp27WT. Further analysis using the Trypan assay would contribute to the 
validity of this result. 
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Figure 3 .11. Hsp27/1 mutation shows similar effects as Hsp27WT. Cells were exposed to 
A~35_25 , A~25_35 or A~ 142 for 24 hr and then subjected to a MTS colormetric assay 
measured at 490nm. Neurons treated with A~ 142 were also subjected to a trypan blue 
assay and were expressed as % of untreated controls (controls not shown). A reduction in 
absorbance is seen for EV and WT transfected cells treated with A~1 _42 but not A~25_35 or 
its control peptide A~35_25 (A). Trypan data shows that Hsp2711 results in greater survival 
than EV neurons (B) but equal to Hsp27WT (C). Each condition is composed of 
absorbance readings from seven replicate wells and trypan data is composed of at least 30 
neurons, over at least 6 fields of view per condition. All data was composed of multiple 
experimental replicates (n=3). All data in figure is displayed as mean± SEM. 
**p<O.OOl (ANOVA), *** p<O.OOOl (T-test) 
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4.1 The Significance of This Study 
Chapter 4 
Discussion 
Hsps can be induced by a variety of environmental stressors such as alcohols, 
heavy metals and heat stress (Hightower, 1991) and are thought to prevent cell death 
through various protective mechanisms such as chaperone activity (Becker and Craig, 
1994, Evans et al., 2006, Parsell and Lindquist, 1993, Rogalla et al., 1999), cytoskeleton 
stabilization (Hargis et al., 2004, Hino et al., 2000, Mounier and Arrigo, 2002, Perng et 
al., 1999), inhibition of apoptotic signals (Garrido et al. 1999, Patel et al., 2005) and 
enhancement of survival pathways (Mearow et al., 2002). Since their discovery in 1962, 
by Ferruccio Ritossa (1962), Hsps' involvement in the stress response has been studied 
with intense investigation. However, the role that Hsps play in neurodegenerative 
diseases such as AD has received relatively little attention. AD is a neurodegenerative 
disease characterized by premature death of a selective neuronal population, especially 
within the frontal and temporal lobes (Mattson, 2004), in the presence of NFfs and 
extracellular neuritic plaques. The amyloid hypothesis asserts that apoptosis is caused by 
the destabilization of the cytoskeleton in the presence of extracellular amyloid plaques 
(Mattson, 2004, Price et al., 1998, Song et al., 2002, Tanzi and Bertram, 2001). My 
thesis sought to investigate the putative protective role of Hsp27 in cortical neurons in 
vitro after treatment with various types of Aj3, namely Aj325_35 and Aj31_42 • Firstly, I 
investigated the endogenous expression of Hsp27, secondly, the protective role of Hsp27 
against Aj3 treatment, and thirdly, the role that Hsp27 has in neurite outgrowth with a 
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particular investigation of mutated Hsp27 !1 (Hsp27!1lacking the WDPF domain and S15 
phosphorylation site), knowing that phosphorylation can influence Hsp27 function 
(Gusev et al., 2002, Lelj-Garolla and Mauk, 2005, Takai et al., 2007, Williams et al., 
2005). 
4.2 Cortical Neurons Lack Endogenous Hsp27 
Hsps are conservative proteins whose expression varies between tissue and cell 
type. For example, Bechtold and Brown (2003) found that hyperthermic induced 
expression of Hsp27 in the cortex was restricted to astrocytes. On the other hand, Hsp70 
is expressed at low levels in the brain under normal conditions but is highly inducible in 
response to injury such as hyperthermia, ischemia or seizure (Armstrong et al. 1996, 
Krueger et al. 1999, Manzerra et al., 1997). Based on the literature and a number of 
studies in our lab (Mearow et al., 2002, Williams et al., 2005), it has been shown that, in 
certain in vitro systems, namely PC12 and cultured DRG neurons , Hsp27 expression can 
be induced by sub-lethal heat shock to afford protection or tolerance against a subsequent 
more noxious stimulus. 
In order to investigate Hsp27' s role in the protection of cortical neurons against 
A~, it seemed appropriate to first investigate endogenous Hsp27 expression. My study 
shows that Hsp27 is not present in cortical neurons, endogenously at 24 or 48 hr after 
heat shock. Since some sHsps require a chemical, and not heat, stress for their 
upregulation, we also analyzed protein lysates from cells exposed to A~ peptides and did 
not find any evidence of Hsp27 expression. Furthermore, we tested for Hsp27 expression 
80 
at 3, 6, and 12 hr time points post heat shock but did not find any indication that Hsp27 is 
expressed endogenously. In agreement with previous aforementioned studies, my 
preliminary experiments show that Hsp27 is not present in cortical neurons in vitro. It 
should be noted that we also conducted PCR analysis on cortical cultures for Hsp27 and 
heat shock factor-1 (Hsf-1, the factor responsible for Hsp27 upregulation). It was found 
that while both Hsp27 and Hsfl mRNA were present they did not display any increases 
after heat shock (Nafar and Mearow, unpublished data). During my preliminary 
experiments, I noticed that heat shock cultures appeared unhealthy (e.g. degenerative 
processes and fragmented cell bodies) following heat shock at 24 and 48 hr time points 
and investigated the survival of cortical neurons by trypan blue assay . It was seen that 
heat shock exposure resulted in significantly less survival in comparison to control at 24 
and 48 hr time points as assessed by the trypan survival assay. Given the delicate nature 
and stress associated with culturing primary neurons it is possible that neurons may not 
have been able to withstand a heat shock treatment of 45°C for 15 min. That being said, 
increasing the recovery period after plating may allow neurons to more fully recover and 
result in healthier, more durable neurons capable of surviving heat shock treatment. 
Furthermore, previous studies (Mearow et al., 2002) performed a media change 1 hr prior 
to heat shock whereas my experiments did not. A media change may have offered a 
protective effect due to the fresh addition of antioxidants, glucose and vitamins. Perhaps 
a media change would have allowed for greater survival in heat shock treated cultures. 
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4.3 Differential Toxicity of AP142 and AP25_25 
Exposure of cells to AP in culture is a well established AD model. AP peptides of 
various lengths have been shown to be toxic in culture (Hardy and Selkoe, 2002), but 
some studies have shown Ap1_42 and AP25_35 to be the predominant toxic species 
(Kawahara and Kuroda, 2000, Pike eta!_, 1993, Resende eta/_, 2007). Ap 1_42 has been 
shown to have a high susceptibility to fibrilize, self aggregate (Harper et al., 1999, Pike et 
al., 1995), generate hydrogen peroxide species (Mattson, 2004), deposit early and 
disproportionately contribute to neuronal toxicity (Price et al., 1998). On the other hand, 
AP25_35 has been shown to be the biologically toxic fragment of the full length AP peptide 
(Yankner et al., 1990). Similarly, both AP142 and AP25_35 have been attributed to forming 
pores in the cellular membrane allowing for ca++ influx and subsequent activation of 
apoptosis (Kawahara and Kuroda, 2000, Resende et al., 2007)_ Both are capable of 
forming fibrilized aggregates but some have suggested that AP fibril formation is not 
necessary for neurotoxicity (Kim et al. , 2003, Klein, 2002, Walsh and Selkoe 2004). 
Consequently, I treated cortical neurons with fresh AP (i.e. not pre-incubated) and 
assessed baseline effects using photomicrographs and the try pan blue assay. However, it 
is possible that AP may begin to aggregate in culture as it has been shown that AP 
aggregation is temperature and time dependent. Typically, AP shows drastic aggregation 
after 7 days in vitro (Pike et al. , 1995) but it is possible that AP could aggregate after two 
days in culture. 
Contrary to the literature, my observations show that AP25_35 did not result in 
significant death in cortical neurons in vitro , while on the other hand AP142 caused a 
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significant reduction in survival. The observation that A~ 1 _42 , but not A~25_35 , resulted in 
significant cell death might be due to the following. Neurotoxicity is directly related to 
aggregation state and A~1 _42 has a high susceptibility to aggregate (Harper et al., 1999). 
Pike et al. (1995) suggested that peptide hydrophobicity may play a role in aggregation, 
as the amount of hydrophobic content in each peptide was proportional to its toxicity . 
Considering that A~ 1 _42 contains twice as many transmembrane (hydrophobic) amino 
acids as A~25 _35 (Fig. 4.1), A~142 may have aggregated sooner than A~25_35 , resulting in 
earlier toxicity. Perhaps if I lengthened the duration of A~ exposure, allowing for A~25_35 
to aggregate, I would observe comparable cell death. Nonetheless, it seems that A~1 _42 is 
more toxic at earlier time points. 
A~25_35 has previously been shown to be toxic at 25 f,LM but our studies did not 
confirm this result (Kawahara and Kuroda, 2000, Pike et al., 1993, Resende et al., 2007). 
I demonstrated that A~25_35 treatment does not result in toxicity as determined by the MTS 
and trypan blue survival assay. A possible reason for this discrepancy is that previous in 
vitro studies showing toxicity after 25 f,LM A~ treatment did not use media supplemented 
with antioxidants (Pike et al., 1995), whereas my culture media contained antioxidants 
from B27 supplement. Given that A~ has been shown to generate oxidative species 
(Mattson, 2004), it is possible that antioxidants included in B27 had a protective effect 
against A~ generated oxidative species. Antioxidant free B27 is available and it might be 
useful to replicate the same experiments described here with antioxidant-free B27 
supplement. 
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4.4 Hsp27 eDNA Protects Neurons After A~ 1 _42 Treatment 
Hsp's actions to prevent cell death have been studied in great detail and the 
mechanisms by which it has been suggested to act include the following: (1) inhibition of 
apoptosis and/or upregulation of survival pathways, (2) chaperone activity, and (3) 
stabilization of the cytoskeleton. There may be other mechanisms by which Hsp27 acts 
to protect cells but these are the main processes of concern in my study. It was shown 
that Hsp27 eDNA protected neurons against A~142 treatment to some degree. In the 
following sections, 4.4.1-4.4.3, I will consider each protective property in relation to my 
observations. 
4.4.1 Inhibition of Apoptosis and Enhancement of Survival Pathways 
Hsp27 has been shown to inhibit cell death by inhibiting apoptosis and promoting 
survival. For example, Hsp27 has been shown to prevent cell death in cells over-
expressing Hsp27 by attenuating caspase-3 and -9 activation (Garrido et al. , 1999, 
Mearow et al., 2002). In addition, Hsp27 has been shown to protect cells by promoting 
Akt activity and it appeared that Hsp27 interacted with Akt in order to sustain its activity, 
suggesting that Hsp27 interacts with survival proteins in order to protect neurons 
(Mearow et al., 2002). Recently, Hsp27 has been shown to regulate Akt via PI3-K and 
concomitantly inhibit Bax mediated cell death (Havasi et al. , 2008). Moreover, Hsp27 
can enhance survival through cytochrome C and fas pathways (Patel et al., 2005), showing 
that Hsp27 's anti-apoptotic/survival effects are ubiquitous in cell death/survival pathways. 
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Knowing this I investigated several stress, apoptotic, and survival signals through 
Western blot analysis, particularly their activated forms. 
pAkt Phosphorylated Akt is an indication of activated Akt and is an integral component 
of survival signaling in many cell types, including neurons (Bijur and Jope, 2000, 
Konishi et al., 1997, Mearow et al. 2002). I sought to explain Hsp27's protective effect 
in part through Akt signaling but unfortunately, I was unable to find a clear response. A 
possible reason for why I was unable to find activation of Akt is that Akt phosphorylation 
is dynamic and can change in a matter of minutes. Some studies in our lab have shown 
peak phosphorylation at 3 hr post heat shock (Mearow et al., 2002). In hindsight, analysis 
of Akt at shorter time points would have been appropriate, and could have allowed me to 
determine whether any survival effects were due to activation of this signaling pathway. 
P-p38 p38 is part of the stress associated MAP-kinase pathway that leads to the 
phosphorylation of Hsp27 (Gusev et al., 2002). Phosphorylated p38 (P-p38) acts on 
MAPKAP-K2 to phosphorylate Hsp27 (Gusev et al., 2002) and our lab has shown its 
activation as early as 6 hr, and up to 24 hr post heat stress (Mearow et al. , 2002). In my 
study I sought to investigate p38 activity in response to A~ treatment and although this 
data is not significant, it was seen that those cultures transfected with Hsp27WT 
demonstrated a trend that p38 was less active than those cultures transfected with empty 
vector. This suggests that Hsp27WT is playing a role to reduce stress in cultures treated 
with A~1 _42 • Considering the literature on Hsp27's involvement in stress (Fig. 4.2) and 
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apoptotic pathways, I also investigated PKC6, JNK and Caspase- 3 but results were not 
consistent. This was likely due to the low amount of protein collected per condition. It 
was often the case that I would collect 30 !!g of protein or less per condition and in some 
of these experiments I did not have equal amounts of sample between lanes. Ideally, I 
would have needed to collect more than 50 !!g of protein per sample and load equivalent 
amounts on my gels. Furthermore, these signals are often present at very low levels. It is 
also possible that the time points I was analyzing were not optimal to observe alterations 
in the activation of these proteins. 
4.4.2 Hsps as Molecular Chaperones 
It is possible that Hsp27 promoted survival by acting as a molecular chaperone, 
as it has been shown that Hsp27 can refold stress-denatured proteins and shuttle damaged 
proteins to the degradation pathway (Becker and Craig, 1994, Parsell and Lindquist, 
1993, Rogalla et al., 1999), two especially important processes in an AD model 
considering that A~ treatment has been shown to act in a hierarchical manner to produce 
NFTs (aggregates of protein tau), resulting in a clogging of the axon and eventual cell 
death. I have shown that the presence of Hsp27WT can protect neurons from A~ induced 
toxicity and it is reasonable to suggest that Hsp27 may have acted to clear aggregated tau 
as Hsp27 has been shown to promote cell survival by binding hyperphosphorylated tau, 
leading to its dephosphorylation and degradation (Shimura et al., 2004) . Clearing of 
NFTs from the axon would allow for normal axonal transport and cytoskeleton growth. 
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An alternative explanation is that Hsp27 could have acted as an antioxidant, 
minimizing the effects of oxidative species generated by Ap1_42 (Mattson, 2004). For 
example, Hsp27 has been shown to protect neuronal cells against superoxide dismutase 
mutant-induced cell death (Patel et al. , 2005), implying that Hsp27 can act as an 
antioxidant to combat the negative metabolic effects of AP 142 • This idea is only 
speculative and a variety of biochemical experiments would be required to make this 
conclusion. 
4.4.3 Hsps Act to Stabilize the Cytoskeleton and Increase Neurite Outgrowth 
It is possible that Hsp27's protective ability may be independent of signaling 
pathways or chaperone activity. For example, Hsp27 has been shown to interact directly 
with the cytoskeleton (Huot et al., 1996, Lavoie et al., 1993, Miron et al., 1991) and 
some have inferred that it can stabilize via actin capping (Benndorf et al. 1994, Mounier 
and Arrigo, 2002). Hsp27 has been shown to bind cytoskeletal related proteins, such as 
vimentin, to maintain a soluble pool of subunits that maintain network integrity (Lee et 
al., 2005), while the related ap-crystallin has demonstrated a similar effect in 
maintaining GFAP networks (Perng et al., 2004), suggesting a general role of Hsp27 
involvement in neuro- and intermediate filament network stability. Furthermore, 
Williams et al. (2006) demonstrated that Hsp27 is required for normal neurite outgrowth 
by showing that the amount of Hsp27 in DRG neurons correlated to neurite length and 
complexity. Interestingly, my study shows that Hsp27 both protects against AP 1_42 
treatment and increases neurite length. 
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I suggest that Hsp27 is stabilizing the axon, resulting in both a prevention of 
destabilization under stress (i.e. A~ treatment) and increased growth under normal 
conditions. Hsp27 can interact with microtubules in muscle cells and some cell lines 
(Hargis et al., 2004, Hino et al., 2000) and has been inferred not only to stabilize actin, 
but neurofilaments, intermediate filaments, MTs and tubulin. This suggests that the 
addition of Hsp27 eDNA could result in a healthier, more stable cytoskeleton with more 
vigorous growth, thus explaining the effect of Hsp27 on neurons in my current study. 
Unfortunately, definitively proving this would require a great deal of analysis beyond my 
project and I can only speculate the mechanism by which Hsp27 could modulate the 
cytoskeleton. Nonetheless, this provides an alternative line of research from which I 
could investigate the effect of Hsp27 on other regions in the CNS. Here, I have 
suggested that Hsp27 can promote survival and stabilize the axonal cytoskeleton. Given 
that the projections between the EC, hippocampus and cortex degenerate early in AD 
(Mattson and Magnus, 2006) it would be reasonable to investigate the effect of Hsp27 on 
axon stability in the entorhinal cortex and limbic structures. Previous studies have 
examined neurite length in EC neurons (Tomozawa and Appel, 1986, Ohshirna et al. , 
2008) and a similar study investigating the effect of Hsp27 on neurite stability with AB1_42 
treatments in vitro in EC neurons may provide a partial explanation for early degeneration 
in these areas. 
My results support the hypothesis that Hsp27 can promote survival in the face of 
amyloid treatment. My results provide preliminary data to support further study on the 
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role of Hsp27 in the protection of cytoskeletal elements as well as investigating relevant 
signaling pathways. 
4.5 The Effect of Hsp27/l on Neurite Outgrowth and Survival 
In order to investigate the role of phosphorylation on neurite outgrowth, I 
employed Hsp27/l eDNA, a mutated version of Hsp27 lacking the WDPF domain. 
Although there was no significant difference between Hsp27/l and Hsp27WT, it is 
interesting that Hsp27/l neurons had shorter processes than Hsp27WT at both time 
points. My results show a trend that neurons without the WDPF and consequently no 
phosphorylation on the S 15 site had shorter neuritic processes. Previous literature 
suggest that non-phosphorylated Hsp27 binds and stabilizes actin filaments by binding to 
the fast growing plus end, acting as an actin capping protein, inhibiting polymerization 
(Benndorf et al. , 1994, Miron et al. , 1991). Our lab has shown that an inhibition of 
phosphorylation at the S15 site by p38 MAPK inhibitor resulted in reduced neurite 
growth or proper neurite extension (Williams et al., 2006). Here, I have shown that 
Hsp27/l neurons show increased neurite length in comparison to control transfected cells 
but not to that of Hsp27WT neurons. 
This result led me to ask whether Hsp27/l could have an effect on survival after 
A~ treatment. It has been shown that the WDPF domain plays a significant role in 
oligomeric structure and chaperone activity (Gusev et al., 2002). With that in mind, I 
returned to a previous experimental design and exposed Hsp27/l transfected neurons to 
both A~25_35 and A~ 142 for 24 hr. Cell survival assays showed there was little difference 
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between the Hsp27 !land Hsp27WT in terms of promoting survival after AP142 treatment. 
This suggests that Hsp27 !lis as effective as Hsp27WT at protecting neurons after AP 142 . 
These results provide an insight into future directions on the effect of phosphorylation of 
Hsp27 in survival against AP 1_42 treatment. Further analysis using the trypan blue assay 
would confirm the effect of Hsp27 !l on survival in AP 142 treated neurons. 
4.6 Future Directions 
This study has investigated the role of Hsp27 in cortical neurons with respect to 
its effects on neurite outgrowth and survival . It has addressed the hypothesis that Hsp27 
could promote survival and stabilize the axonal cytoskeleton resulting in maintenance of 
neurite growth and axonal transport in the face of stressors such asAp. It was shown that 
Hsp27 is both important for survival and neurite outgrowth. However, a number of 
questions remain concerning the mechanisms that attenuate Ap1_42 induced neuronal death 
in Hsp27 transfected cortical neurons. For instance, it is unknown if Hsp27 is protecting 
neurons by acting to reduce cell death via signaling pathways or chaperone activity, or 
both. In addition , it remains unknown how Hsp27 facilitates neurite growth and whether 
its survival effects are linked by stabilizing the cytoskeleton. 
Given AD's impact on the EC and basal forebrain (Davies and Maloney, 1976, 
Cassel et al., 2008, Frolich, 2002, Muth et al., 2009 Pappas et al. , 2000) , it would be 
relevant to investigate the protective role of Hsp27 in these neurons. An analysis of 
Hsp27's role in protecting entorhinal neurons in vitro against AB, _42 has yet to be 
conducted and such a study would provide a more comprehensive investigation of 
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Hsp27's role in neuroprotection of the CNS. Hsp27 has been shown to be upregulated in 
glial (Bidmon et al., 2005) and neuronal cells (Kato et al., 1991) of the EC and the limbic 
system in response to ischemia and seizure, respectively. More interestingly , it was 
shown that HspA5 (Grp78, glucose regulatory protein) and Hsp72 were upregulated in 
surviving neurons of the EC and hippocampus of AD patients, suggesting that Hsps can 
play a role in cell survival in these regions (Hamos et al., 1991 , Ohshima et al. , 2008). 
Thus, it seems reasonable to further investigate the effect of AB,_42 on Hsp27 transfected 
EC neurons in vitro. I should note that my initial experiments employed the use of 
cultured hippocampal neurons but because of the high number of non-neuronal cells in 
these cultures, I decided to pursue my experiments with cortical cultures, where there was 
less glial cell contamination. 
I demonstrated that Aj325_35 was not toxic to cortical neurons in vitro, while 
previous studies at the same concentration have concluded that Aj325_j5 is the toxic 
fragment of the full length peptide (Pike et al., 1993) and reasons for this discrepancy are 
unknown. Given the literature and Hsp27's effect on survival and neurite growth in my 
study, it is my suggestion that Hsp27 acts to stabilize the axon during stress and prevents 
its degradation and neuronal death . However, many more experiments are required to 
support this conclusion and given the scope of this topic, my thesis can provide a basis 
which to further investigate this conjecture. 
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Figure 4.1. Hydrophobic regions in A~142 and Aj325.35 • It is thought that hydrophobicity is 
related to toxicity (Adapted from Pike et al., 1993). 
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Appendix 1 
EGFP-Hsp27 
Endogenous 
Level 
Figure 5 .1. Western Blot shows undetectable levels of endogenous Hsp27 in untreated 
and AB1_42 treated conditions. Cortical neurons were plated on poly-D-lysine coated 
dishes, allowed to mature for two days in culture and then treated with A./31_42 for 24 and 
48 hr. Although Hsp27WT fusion protein is present, it can be seen that endogenous 
Hsp27 is not detectable in any experimental condition. 
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